Regulation & law · 22/05/2012
Mylan Pharmaceuticals, Inc. Notifies the DEA of Its Registration as an Importer of Controlled Substances
Mylan Pharmaceuticals, Inc. has submitted a Notice of Registration to the U.S. Drug Enforcement Administration (DEA), confirming its status as an importer of controlled substances, as required by law.
Original source language: Federal Register — Justice DepartmentOpen original release →